Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ALPNALPN
8 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in ALPINE IMMUNE SCIENCES INC

As of its Q1 2024 13F, Qube Research & Technologies held 163,323 shares of ALPN (Alpine Immune Sciences), worth $6.5M. Qube Research & Technologies' 13F filings listed ALPN from Q3 2023 to Q1 2024, 3 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$329,000

Total Shares Change

-37,377

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Decreased
163,323
-20.6%
$6.5M0.0%—
0
2023-Q4
Increased
205,766
+1943.4%
$3.9M0.0%—
43
2023-Q3
New
10,070
-
$115,3020.0%—
30
2021-Q2
Exited
0
-100.0%
$00.0%—
0
2021-Q1
Decreased
14,562
-68.7%
$154,0000.0%—
0
2020-Q4
Increased
46,556
+24.6%
$587,0000.0%—
30
2020-Q3
New
37,377
-
$329,0000.0%—
33

Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used